Aggregated
75% success rate- Bullish
- 0
- Hold
- 1
- Bearish
- 0
Stifel
A Stifel analyst with 5 tracked ratings spanning 5 distinct tickers has issued 1 hold rating and maintains a 75% success rate on the captured sample, focusing exclusively on the covered sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| ERAS | 2026-04-27 | buy | $30.00 | Aggregated |
| TNGX | 2026-04-27 | buy | $40.00 | Aggregated |
| RVMD | 2026-04-20 | buy | $215.00 | Aggregated |
| BBOT | 2026-02-11 | buy | $23.00 | Aggregated |
| RVMD | 2026-01-22 | buy | $170.00 | Aggregated |
| FHTX | 2025-12-04 | buy | $12.00 | Aggregated |
| NUVL | 2025-11-17 | buy | $135.00 | Aggregated |
| BDTX | 2025-10-16 | buy | $8.00 | Aggregated |
| BDTXBLACK DIAMOND THERAPEUTICS INC | 2025-10-16 | unknown | $8.00 | Aggregated |
| COGT | 2025-10-16 | hold | $16.00 | Aggregated |
| COGTCOGENT BIOSCIENCES INC | 2025-10-16 | hold | $16.00 | Aggregated |
| ERAS | 2025-10-16 | buy | $4.00 | Aggregated |
| ERASERASCA INC | 2025-10-16 | unknown | $4.00 | Aggregated |
| NUVL | 2025-10-16 | buy | $115.00 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 2025-10-16 | unknown | $115.00 | Aggregated |
| RVMDREVOLUTION MEDICINES INC | 2025-10-16 | unknown | $85.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| ERAS | 2 | 2026-04-27 | Aggregated |
| TNGX | 1 | 2026-04-27 | Aggregated |
| RVMD | 2 | 2026-04-20 | Aggregated |
| BBOT | 1 | 2026-02-11 | Aggregated |
| FHTX | 1 | 2025-12-04 | Aggregated |
| NUVL | 2 | 2025-11-17 | Aggregated |
| BDTX | 1 | 2025-10-16 | Aggregated |
| BDTXBLACK DIAMOND THERAPEUTICS INC | 1 | 2025-10-16 | Aggregated |
| COGT | 1 | 2025-10-16 | Aggregated |
| COGTCOGENT BIOSCIENCES INC | 1 | 2025-10-16 | Aggregated |
| ERASERASCA INC | 1 | 2025-10-16 | Aggregated |
| NUVLNUVALENT INC - ORDINARY SHARES - CLASS A | 1 | 2025-10-16 | Aggregated |
| RVMDREVOLUTION MEDICINES INC | 1 | 2025-10-16 | Aggregated |